FDA May Reclassify ECT Devices
FDA May Reclassify ECT Devices
The FDA may reclassify electroconvulsive therapy devices from class III to class II. The FDA is accepting public comments on the change until March 28.
ECT: Dangerous on Either Side of the Pond
Left to Their Own Devices: Breakdowns in United States Medical
ECT Device Manufacturer Admits Brain Damage as a Risk of
Why the FDA's Move to Restrict ECT Should Alarm Us All
Psychiatrists Urged to Support ECT Reclassification
ECT Device Manufacturer Admits Brain Damage as a Risk of
FDA Downgrades Risk Category for Certain Uses - Psych News Alert
ECT Safety Reclassification: Psychiatrist Daniel P. Fisher to FDA
Electroconvulsive therapy - Wikipedia
F.D.A. Is Studying the Risk of Electroshock Devices
When to consider electroconvulsive therapy (ECT) - Kellner - 2020
